| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |